Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
RFK, I think he is really looking at those avenues
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Plus, it significantly lightens pigmentation but does not lighten normal skin
This evidence-based approach ensures you invest in the most effective treatment from the start, saving money on alternatives that wont work for your specific biology
By changing how fat cells store and release energy, 5-Amino-1MQ may help make these areas more responsive
